Squarepoint’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-117,506
| Closed | -$364K | – | 3876 |
|
|
2021
Q4 | $364K | Buy |
+117,506
| New | +$395K | ﹤0.01% | 2346 |
|
|
2021
Q3 | – | Sell |
-59,726
| Closed | -$214K | – | 3769 |
|
|
2021
Q2 | $214K | Sell |
59,726
-66,721
| -53% | -$235K | ﹤0.01% | 2783 |
|
|
2021
Q1 | $494K | Buy |
126,447
+56,170
| +80% | +$232K | ﹤0.01% | 2039 |
|
|
2020
Q4 | $295K | Sell |
70,277
-103,631
| -60% | -$399K | ﹤0.01% | 2218 |
|
|
2020
Q3 | $649K | Buy |
173,908
+30,260
| +21% | +$129K | 0.01% | 1234 |
|
|
2020
Q2 | $626K | Sell |
143,648
-268,374
| -65% | -$1.21M | 0.01% | 1180 |
|
|
2020
Q1 | $1.56M | Sell |
412,022
-108,192
| -21% | -$532K | 0.04% | 530 |
|
|
2019
Q4 | $3.29M | Buy |
520,214
+7,934
| +2% | +$46.6K | 0.02% | 645 |
|
|
2019
Q3 | $2.16M | Buy |
512,280
+19,751
| +4% | +$84.4K | 0.02% | 818 |
|
|
2019
Q2 | $2.29M | Buy |
492,529
+204,710
| +71% | +$953K | 0.02% | 768 |
|
|
2019
Q1 | $1.52M | Buy |
287,819
+248,119
| +625% | +$1.13M | 0.02% | 889 |
|
|
2018
Q4 | $147K | Buy |
+39,700
| New | +$139K | ﹤0.01% | 1755 |
|
|
2016
Q3 | – | Sell |
-95,000
| Closed | -$224K | – | 1495 |
|
|
2016
Q2 | $224K | Buy |
95,000
+53,600
| +129% | +$148K | 0.01% | 853 |
|
|
2016
Q1 | $134K | Buy |
41,400
+7,500
| +22% | +$27.7K | 0.01% | 1049 |
|
|
2015
Q4 | $162K | Buy |
+33,900
| New | +$192K | 0.02% | 1059 |
|
Other funds holding BDSI
Squarepoint's BDSI Position: Q1 2022 in Review
Squarepoint sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 117,506 shares — an estimated $364K sold.
Squarepoint first reported a position in BDSI in Q4 2015 and held it in 15 quarters. The position peaked at $3.29M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Squarepoint reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Squarepoint sold 117,506 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $364K.
- Squarepoint first reported a position in BioDelivery Sciences International, Inc. in Q4 2015 and held it in 15 quarters.
- Squarepoint's BioDelivery Sciences International, Inc. position peaked at $3.29M in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.